181765-11-7

Usage

Uses

Used in Pharmaceutical Industry:
25-Anhydrocimigenol 3-O-beta-D-xyloside is used as a pharmaceutical agent for its anti-inflammatory properties, which can help in the treatment of various inflammatory conditions.
25-Anhydrocimigenol 3-O-beta-D-xyloside is used as an anti-cancer agent for its potential to inhibit the growth and progression of cancer cells, making it a valuable component in the development of new cancer therapies.
Used in Neuroprotective Applications:
25-Anhydrocimigenol 3-O-beta-D-xyloside is used as a neuroprotective agent to protect the nervous system and prevent neurodegenerative diseases due to its neuroprotective activities.
Used in Bone Health and Osteoporosis Treatment:
25-Anhydrocimigenol 3-O-beta-D-xyloside is used as a bone health supplement and osteoporosis treatment to improve bone density and strength, reducing the risk of fractures and other bone-related issues.
Used in Antioxidant and Anti-aging Products:
25-Anhydrocimigenol 3-O-beta-D-xyloside is used as an antioxidant and anti-aging ingredient in cosmetic and skincare products to protect the skin from oxidative stress and promote a youthful appearance.

Upstream product

• 1140532-49-5 (3β,9β,15α,16β,23R,24R)-15,16-dihydroxy-3-(β-D-xylopyranosyloxy)-16,23-epoxy-9,19-cyclolanost-25-en-24-yl acetate 

Relevant academic research and scientific papers

Four new 9,19-cyclolanostane derivatives from the rhizomes of Cimicifuga yunnanensis hsiao

Four new 9,19-cyclolanostane-type triterpenes, 24-O-acetyl-25- anhydroshengmanol-3-O-β-d-xylopyranoside (1), 25-i-butylcimigenol-3-O- β-d-xylopyranoside (2), 12-β-hydrocimigenol-3-one (3), and 12-β-hydrocimigenol-1-en-3-one (4), together with 15 known ana

Cycloartane triterpenoids from the aerial parts of Cimicifuga foetida Linnaeus

Cycloartane triterpenoids, 2′,24-O-diacetylisodahurinol-3-O-α- l-arabinopyranoside, 24-O-acetylisodahurinol-3-O-α-l-arabinopyranoside, 12β-hydroxy-25-anhydrocimigenol, cimigenol-12-one, 12β-hydroxy-15- deoxycimigenol, 2′-O-acetyl-24-epi-cimigenol-3-O-α-l- arabinopyranoside, 2′-O-acetylcimigenol-3-O-β-d-xylopyranoside, 25-anhydrocimigenol-3-O-α-l-arabinopyranoside, 2′,23-O- diacetylshengmanol-3-O-α-l-arabinopyranoside, and 2′,24-O-diacetyl- 25-anhydrohydroshengmanol-3-O-α-l-arabinopyranoside, together with eight known compounds, were isolated from aerial parts of Cimicifuga foetida. Their structures were determined by application of spectroscopic analyses and chemical methods. Biological evaluation of the compounds against human HL-60, SMMC-7721, A549, SK-BR-3, and PANC-1 cell lines indicated that three of these compounds exhibited broad-spectrum and moderate cytotoxic activities, with IC50 values ranging from 6.20 to 22.74 μM. By comparing previous cytotoxic testing data and bioassay results from this study, preliminary structure-activity relationships of compounds with a cimigenol-skeleton can be proposed.